SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Frank McCormick, Ph.D., F.R.S., has been selected by Fluidigm Corporation as the newest member of its Scientific Advisory Board (SAB). Dr. McCormick is director of the University of California, San Francisco (UCSF) Comprehensive Cancer Center and Cancer Research Institute, one of the largest multidisciplinary research and clinical care organizations in the western United States. Prior to joining the UCSF faculty, Dr. McCormick held prominent positions with several Bay Area firms pursuing cancer-related therapies, including Cetus Corporation (1981 - 1991) and Chiron Corporation (1991 – 1992). In 1992 he founded Onyx Pharmaceuticals and served as its Chief Scientific Officer until 1996.
